Though OpenAI still operates a non-financial gain arm, it officially grew to become a “capped earnings” Company in 2019. A March 2023 paper analyzed ChatGPT's software in scientific toxicology. The authors observed that the AI "fared perfectly" in answering a "very straightforward [clinical scenario case in point], not likely being https://chat-gpt-4-login42197.onesmablog.com/rumored-buzz-on-chatting-gpt-69893710